These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 25302802)

  • 1. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
    Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
    Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
    Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
    Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health.
    Fabian C; Naaldijk Y; Leovsky C; Johnson AA; Rudolph L; Jaeger C; Arnold K; Stolzing A
    Stem Cell Res Ther; 2017 Apr; 8(1):85. PubMed ID: 28420415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease.
    Kang EJ; Lee YH; Kim MJ; Lee YM; Kumar BM; Jeon BG; Ock SA; Kim HJ; Rho GJ
    J Tissue Eng Regen Med; 2013 Mar; 7(3):169-82. PubMed ID: 22081626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
    Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
    Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
    Lee JK; Jin HK; Bae JS
    Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
    Lee JK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
    Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
    Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
    Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
    Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
    Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
    Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease.
    Yu-Taeger L; Stricker-Shaver J; Arnold K; Bambynek-Dziuk P; Novati A; Singer E; Lourhmati A; Fabian C; Magg J; Riess O; Schwab M; Stolzing A; Danielyan L; Nguyen HHP
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
    Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
    Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration.
    Lampron A; Pimentel-Coelho PM; Rivest S
    J Comp Neurol; 2013 Dec; 521(17):3863-76. PubMed ID: 23682015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
    Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
    Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
    Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
    Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.